Terada Tadashi
Department of Pathology, Shizuoka Municipal Shimizu Hospital, Japan.
Appl Immunohistochem Mol Morphol. 2011 Oct;19(5):450-3. doi: 10.1097/PAI.0b013e31820d2872.
Protein expression and gene mutational status of KIT and PDGFRA were investigated in formalin-fixed, paraffin-embedded specimens of 14 ipsilateral testicular seminomas. The analysis was performed by ordinary immunohistochemistry and polymerase chain reaction-direct sequencing methods. The genetic analysis was performed in exons 9, 11, 13, and 17 of KIT gene and in exons 12 and 18 of PDGFRA gene. Six point mutations of 5 types of KIT gene were recognized in 5 (36%) cases; exon 17 around codon 816 was a hotspot. The mutation sites of KIT gene were as follows: codon 557 in exon 11 (1 case), codon 816 in exon 17 (3 cases), codon 820 in exon 17 (1 case), and codon 822 in exon 17 (1 case). One patient showed multiple mutations of KIT gene. Immunoreactive KIT was recognized in 13 (93%) cases; the expression was strong in the 5 KIT mutation-positive cases, but variable or none in the 9 KIT mutation-negative cases. No PDGFRA gene mutations were observed in all the 14 cases. PDGFRA protein expression was weakly recognized in 12 cases but none in the remaining 2 cases. These data suggest, in testicular seminomas, that 36% of ipsilateral testicular seminomas have KIT mutations, KIT mutations are frequent around codon 816 of exon 17, multiple KIT mutations may be present, KIT expression is stronger in KIT mutation-positive cases than negative cases, PDGFRA gene mutations are absent, and PDGFRA protein is weakly expressed.
在14例同侧睾丸精原细胞瘤的福尔马林固定、石蜡包埋标本中,研究了KIT和PDGFRA的蛋白表达及基因突变状态。分析采用普通免疫组织化学和聚合酶链反应-直接测序方法进行。基因分析在KIT基因的第9、11、13和17外显子以及PDGFRA基因的第12和18外显子中进行。在5例(36%)病例中识别出5种类型的KIT基因的6个点突变;第17外显子密码子816周围是一个热点。KIT基因的突变位点如下:第11外显子的密码子557(1例)、第17外显子的密码子816(3例)、第17外显子的密码子820(1例)和第17外显子的密码子822(1例)。1例患者显示出KIT基因的多个突变。在13例(93%)病例中识别出免疫反应性KIT;在5例KIT突变阳性病例中表达强烈,但在9例KIT突变阴性病例中表达可变或无表达。在所有14例病例中均未观察到PDGFRA基因突变。12例病例中弱识别出PDGFRA蛋白表达,但其余2例病例中未识别到。这些数据表明,在睾丸精原细胞瘤中,36%的同侧睾丸精原细胞瘤存在KIT突变,KIT突变在第17外显子密码子816周围频繁出现,可能存在多个KIT突变,KIT突变阳性病例中的KIT表达强于阴性病例,不存在PDGFRA基因突变,且PDGFRA蛋白弱表达。